Silver Book

Silver Book reference

An Unhealthy America: The economic burden of chronic disease

Reference

Publisher
The Milken Institute
Publication Date
2007
Authors
DeVol R, Bedroussian A, Charuworn A, Chatterjee A, et al.
URL
Read Full Resource

41 Matching Facts

Search matching Facts:
No results to display
    • Avoidable Treatment Expenditures, 2023  
    • State Chronic Disease Index  
    • Projected Rise in Cases of Chronic Diseases, 2003-2023  
    • Population Projections: 65 and over
      Population Projections: 65 and over  
    • Number of People Reporting Selected Chronic Diseases, 2003  
    • Number of People Reporting Selected Cancers, 2003  
    • Lost Productivity by Source, 2003  
    • Lost Productivity by Chronic Disease, 2003  
    • Percent Growth in Number of People Reporting Chronic Diseases, 2003-2023: Current Path versus Alternative Path  
    • Economic Impact of Chronic Disease, 2003  
    • Current Path, Combined Value of Treatment Expenditures and Productivity Losses, 2003-2023  
    • Costs That Can Be Avoided, 2003-2023  
    • Avoidable Treatment Costs and Output Losses, 2023  
    • Avoidable Productivity Losses, 2023  
    • Projected Annual Costs of Chronic Diseases, 2023 (US$ Trillions)  
    • Following the current path, stroke cases will increase by 28.9% between 2003 and 2023 (estimates do not include strokes among the institutionalized population). If an alternative path is taken, there…  
    • Following the current path, heart disease cases will increase by 41.1% between 2003 and 2023.  
    • Following the current path, heart disease cases will increase by 41.1% between 2003 and 2023. If an alternative path is taken, there will be 34.6% (9.4 million) fewer heart disease…  
    • Following the current path, diabetes cases will increase by 52.9% between 2003 and 2023.  
    • Following the current path, diabetes cases will increase by 52.9% between 2003 and 2023. If an alternative path is taken, there will be 13.3% (2.8 million) fewer diabetes cases.  
    • Following the current path, pulmonary condition cases will increase by 31.3% between 2003 and 2023.  
    • Following the current path, pulmonary condition cases will increase by 31.3% between 2003 and 2023. If an alternative path is taken, there will be 9.1% fewer pulmonary condition cases.  
    • Following the current path, the colon cancer incidence rate will increase by 31.8% between 2003 and 2023 (447,000 people). If an alternative path is taken, there will be 17.7% (79,000…  
    • Following the current path, the lung cancer incidence rate will increase by 34% between 2003 and 2023. If an alternative path is taken, there will be 18.4% (92,000) fewer lung…  
    • Following the current path, the prostate cancer incidence rate will increase by 75.4% (786,000) between 2003 and 2023.  
    • Following the current path, the prostate cancer incidence rate will increase by 75.4% (786,000) between 2003 and 2023. If an alternative path is taken, there will be 21.5% (393,000) fewer…  
    • Following the current path, the lung cancer incidence rate will increase by 34% between 2003 and 2023.  
    • Following the current path, colon cancer incidence rate will increase by 31.8% (447,000 people) between 2003 and 2023.  
    • Following the current path, breast cancer incidence rate will increase by 50.8% between 2003 and 2023.  
    • Following the current path, breast cancer incidence rate will increase by 50.8% between 2003 and 2023. If an alternative path is taken, cases will increase by 32.2% between 2003 and…  
    • Changes in behavior, preventative measures and innovation could save $1.6 trillion in treatment costs.  
    • In an optimistic scenario, more effective prevention and management of disease could save $218 billion in treatment expenditures annually in 2023.  
    • The total annual economic burden of 7 major chronic diseases. including cost of expenditures, will be $4.2 trillion in 2023.  
    • The indirect impacts of 7 major chronic diseases will total $3.4 trillion in 2023– which is 4 times the cost of treatment.  
    • Increase in 65 and older population, 2003 to 2030
      The U.S. census bureau projects a rise in the 65 and older population, from 12.4% in 2003 to 17.4% in 2030.  
    • A man between 65 and 74 is 167.2 times more likely to develop prostate cancer than a male under age 50.  
    • Lost workdays and lower employee productivity because of hypertension cost $279.5 billion– the highest amount among chronic diseases.  
    • Chronic disease cost $42 trillion in treatment costs and economic output.  
    • In 2030 there will be a 42% increase in cases of chronic diseases– 230.7 million people.  
    • The most common chronic diseases are costing the U.S. more than $1 trillion per year– which is expected to increase to $6 trillion by the middle of the century.  
    • More than half of Americans suffer from one or more chronic diseases.